Science 37 Expects FY23 Revenues Of $60M, Versus $56.94M Consensus (Prior View: $55M-$60M)
Portfolio Pulse from Benzinga Newsdesk
Science 37 Holdings, Inc. (NASDAQ:SNCE) has revised its FY23 adjusted EBITDA guidance to approximately $(35.0) million, an improvement from the previously conveyed range of $(39.0) million to $(41.0) million. The company also expects FY23 revenues of $60M, slightly above the consensus of $56.94M and the prior view of $55M-$60M.
August 08, 2023 | 10:12 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Science 37's improved EBITDA guidance and higher-than-expected revenue forecast for FY23 could potentially boost investor confidence and positively impact the company's stock price in the short term.
Science 37's revised EBITDA guidance indicates an improvement in the company's financial performance. Additionally, the company's FY23 revenue forecast is higher than the consensus, which could be perceived positively by the market. These factors could potentially lead to an increase in the company's stock price in the short term.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 100